Treatment of Depression with Acupuncture Based on Pathophysiological Mechanism
Sun et al. · International Journal of General Medicine · 2024
Evidence Level
MODERATEOBJECTIVE
To review the pathophysiologic mechanisms of acupuncture in the treatment of depression
WHO
Patients with depression across the studies reviewed
DURATION
Review of studies published through 2024
POINTS
Various acupuncture points, including electroacupuncture and auricular acupuncture
🔬 Study Design
Narrative Review
n=0
Analysis of multiple studies on acupuncture and depression
📊 Results in numbers
Increase in serotonin levels
Reduction in cortisol
Improvement in neuroplasticity
Reduction in inflammation
📊 Outcome Comparison
Identified mechanisms of action
This study shows that acupuncture works against depression through several mechanisms in the brain, including increased neurotransmitters such as serotonin, reduced inflammation, and improvement in the brain's capacity to adapt. Acupuncture may be a safe and effective alternative to antidepressant medications, with fewer side effects.
Article summary
Plain-language narrative summary
This review, published in the International Journal of General Medicine in 2024, presents a comprehensive analysis of the pathophysiologic mechanisms through which acupuncture acts in the treatment of depression. The authors, Sun and colleagues, conducted a narrative literature review to explore how this ancient therapy can offer a safe and effective alternative to conventional depression treatments. Depression is recognized as a prevalent mental disorder that profoundly affects an individual's psychologic and physical well-being, characterized by persistently depressed mood, loss of interest, decreased energy, and cognitive dysfunction. The study highlights that, although traditional treatments rely mainly on medications and psychotherapy, these methods are not always effective for every patient and frequently produce significant side effects.
The investigators identified four principal mechanisms by which acupuncture exerts its antidepressant effects. The first mechanism involves the modulation of neurotransmitter levels. Acupuncture has been shown to increase serotonin, dopamine, and norepinephrine levels in the brain — neurotransmitters fundamental to mood regulation. Animal-model studies have shown that acupuncture can significantly increase activity at 5-HT1A and 5-HT1B receptors, thereby improving depressive behavior.
Electroacupuncture, a variation of the traditional technique, has proved particularly effective in modulating the dopaminergic system in the prefrontal cortex. The second mechanism identified is modulation of the neuroendocrine axis, particularly the hypothalamic-pituitary-adrenal (HPA) axis. In patients with depression, this axis frequently shows hyperactivity, resulting in elevated cortisol levels. Acupuncture has been shown to lower blood cortisol levels and reduce HPA-axis hyperactivity, restoring the balance between the sympathetic and parasympathetic nervous systems.
This homeostatic effect not only reduces depressive symptoms but also promotes overall neuroendocrine balance. The third mechanism involves the enhancement of neuroplasticity. Neuroplasticity, which refers to the nervous system's capacity to adapt to environmental change, tends to be impaired in patients with depression. Acupuncture has been shown to promote the growth and reconstruction of nerve cells in the brain through activation of the BDNF/mTORC1 signaling pathway.
This pathway is crucial for the formation and functional maintenance of synaptic connections. Studies have shown that acupuncture can increase the expression of synapse-related proteins such as PSD95, synapsin I, and GluR1 and increase dendritic spine density in the prefrontal cortex. The fourth mechanism identified is acupuncture's anti-inflammatory effect. Depression is frequently associated with an increased inflammatory response, with patients showing elevated levels of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6.
Acupuncture has been shown to reduce the production and release of these inflammatory mediators while promoting the release of anti-inflammatory factors such as IL-10. Animal studies have shown that acupuncture can inhibit activation of the NLRP3 inflammasome, a protein complex involved in the inflammatory response and pyroptotic cell death. The clinical results presented in the review consistently show that acupuncture can significantly improve depressive symptoms through these multiple mechanisms. In animal models of depression, acupuncture has been shown to reduce depressive behaviors, improve neurologic function, and normalize biomarkers associated with depression.
Electroacupuncture, in particular, has proved effective in reversing behavioral changes induced by chronic stress and restoring normal synaptic function. The clinical implications of these findings are substantial. Acupuncture offers a therapeutic approach that acts through multiple biologic pathways simultaneously, providing a comprehensive antidepressant effect. Unlike conventional antidepressant medications, which frequently cause side effects such as nausea, vomiting, diarrhea, and sexual dysfunction, acupuncture has a superior safety profile.
In addition, acupuncture's capacity to modulate neurotransmitters, inflammation, neuroplasticity, and the neuroendocrine system simultaneously suggests that it may be particularly effective for patients who do not respond adequately to conventional treatments. However, the authors acknowledge important limitations of their review. The quality and quantity of research on acupuncture are still insufficient to establish it as a broadly accepted medical treatment. In addition, the efficacy of acupuncture varies among individuals, and the technique, if not performed appropriately, can cause side effects such as infection, bleeding, and needle injuries.
Acupuncture treatment also requires multiple sessions and can be time-consuming, which may represent an inconvenience for some patients. The investigators emphasize the need for more controlled and randomized clinical trials to confirm these mechanisms in human populations and establish standardized treatment protocols. They also highlight the importance of considering cultural factors and individual beliefs, given that acupuncture is deeply influenced by the philosophy of traditional Chinese medicine, which may not be compatible with the cultural context of every patient.
Strengths
- 1Comprehensive mechanistic approach across multiple biologic pathways
- 2Review of broad literature including animal and human studies
- 3Clear identification of four principal mechanisms of action
- 4Balanced discussion that includes limitations and practical considerations
Limitations
- 1Narrative review without quantitative meta-analysis
- 2Most mechanistic studies performed in animal models
- 3Need for more controlled clinical trials in humans
- 4Individual variability in treatment response not quantified
Expert Commentary
Prof. Dr. Hong Jin Pai
PhD in Sciences, University of São Paulo
▸ Clinical Relevance
Depression represents one of the greatest therapeutic challenges in contemporary medicine, and this review contributes by systematizing the biologic mechanisms that support the use of acupuncture in this setting. For the clinician seeing patients with refractory depression, intolerance to antidepressants, or refusal to use psychotropic medications, acupuncture now has a clear mechanistic rationale rather than a purely empirical one. The simultaneous modulation of monoaminergic neurotransmitters, the hypothalamic-pituitary-adrenal axis, neuroplasticity via BDNF/mTORC1, and inflammatory pathways — including inhibition of the NLRP3 inflammasome — gives acupuncture a spectrum of action that a single antidepressant rarely covers. This positions the technique as a genuinely integrative option, particularly for patients with depression associated with chronic inflammatory conditions, metabolic syndrome, or comorbid chronic pain — populations commonly seen in tertiary care.
▸ Notable Findings
The identification of the BDNF/mTORC1 pathway as one of the central axes of acupuncture's antidepressant action deserves close attention, as this is precisely the pathway activated by ketamine in its well-known rapid-onset antidepressant action. This mechanistic parallel is not trivial. Equally notable is the documented effect on the NLRP3 inflammasome — an emerging target in psychiatric research — suggesting that acupuncture may act on neuroinflammation in a manner distinct from classical antidepressants. The capacity to selectively increase activity at 5-HT1A and 5-HT1B receptors, observed in animal models, and to modulate the prefrontal dopaminergic system through electroacupuncture points to real pharmacologic specificity, moving away from the narrative of a purely non-specific effect. The concurrent rise in IL-10 alongside reductions in TNF-α, IL-1β, and IL-6 reinforces a bidirectional immunomodulatory profile.
▸ From My Experience
In my practice at the Pain Center of HC-FMUSP, I have treated patients with depression predominantly as a comorbidity of chronic painful conditions, and the response I observe is consistent with what this review describes mechanistically. I tend to perceive the first changes in mood and energy around the fourth to sixth session, generally before any objective improvement on the pain scale. For cases of mild to moderate depression, a course of 10 to 12 weekly sessions is usually enough to consolidate the response; more severe cases or those with a long history of refractoriness require maintenance every other week for several months. I routinely combine acupuncture with ongoing psychiatric treatment — I never propose it as a substitute for specialized care — and I have noted that patients on SSRIs who add acupuncture frequently report faster improvement and better medication tolerance. The profile that responds best, in my experience, is the patient with clinically evident hypercortisolism, prominent somatic anxiety, and an associated inflammatory component.
Full original article
Read the full scientific study
International Journal of General Medicine · 2024
DOI: 10.2147/IJGM.S448031
Access original articleScientific Review

Marcus Yu Bin Pai, MD, PhD
CRM-SP: 158074 | RQE: 65523 · 65524 · 655241
PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.
Learn more about the author →Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.
Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.
Related articles
Based on this article’s categories